Lorraine Durcan

6.6k total citations
10 papers, 454 citations indexed

About

Lorraine Durcan is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Lorraine Durcan has authored 10 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Lorraine Durcan's work include Breast Cancer Treatment Studies (5 papers), Cancer Risks and Factors (3 papers) and Global Cancer Incidence and Screening (3 papers). Lorraine Durcan is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer Risks and Factors (3 papers) and Global Cancer Incidence and Screening (3 papers). Lorraine Durcan collaborates with scholars based in United Kingdom, Australia and Germany. Lorraine Durcan's co-authors include Diana Eccles, Ellen Copson, Tom Maishman, Ramsey Cutress, Louise Stanton, Sue Gerty, J. Louise Jones, Bryony Eccles, Peter Simmonds and Douglas G. Altman and has published in prestigious journals such as Nature Communications, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Lorraine Durcan

10 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lorraine Durcan United Kingdom 9 310 281 121 94 83 10 454
C. I. Li United States 6 305 1.0× 176 0.6× 113 0.9× 74 0.8× 44 0.5× 7 439
В. В. Семиглазов Russia 8 345 1.1× 269 1.0× 102 0.8× 47 0.5× 102 1.2× 83 505
Shan Zheng China 13 271 0.9× 133 0.5× 48 0.4× 106 1.1× 103 1.2× 41 482
Fredrika Killander Sweden 12 199 0.6× 240 0.9× 46 0.4× 54 0.6× 73 0.9× 25 411
Sabine Pöstlberger Austria 7 288 0.9× 385 1.4× 106 0.9× 73 0.8× 63 0.8× 10 502
Olivier Brouckaert Belgium 10 229 0.7× 203 0.7× 77 0.6× 49 0.5× 55 0.7× 24 381
A. Michelotti Italy 11 210 0.7× 108 0.4× 27 0.2× 67 0.7× 100 1.2× 15 372
Mauricio Camus Chile 13 143 0.5× 187 0.7× 169 1.4× 211 2.2× 32 0.4× 49 487
Hatef Darabi Sweden 11 210 0.7× 89 0.3× 171 1.4× 84 0.9× 82 1.0× 21 408
Sara Taylor Canada 9 242 0.8× 123 0.4× 33 0.3× 180 1.9× 63 0.8× 16 361

Countries citing papers authored by Lorraine Durcan

Since Specialization
Citations

This map shows the geographic impact of Lorraine Durcan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorraine Durcan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorraine Durcan more than expected).

Fields of papers citing papers by Lorraine Durcan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorraine Durcan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorraine Durcan. The network helps show where Lorraine Durcan may publish in the future.

Co-authorship network of co-authors of Lorraine Durcan

This figure shows the co-authorship network connecting the top 25 collaborators of Lorraine Durcan. A scholar is included among the top collaborators of Lorraine Durcan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorraine Durcan. Lorraine Durcan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
McKenzie, Hayley, Tom Maishman, Peter Simmonds, et al.. (2020). Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients. British Journal of Cancer. 122(11). 1618–1629. 22 indexed citations
2.
Gandhi, Ashu, Ellen Copson, Diana Eccles, et al.. (2019). Predictors of weight gain in a cohort of premenopausal early breast cancer patients receiving chemotherapy. The Breast. 45. 1–6. 19 indexed citations
3.
Kadalayil, Latha, Sofia Khan, Heli Nevanlinna, et al.. (2017). Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women. Nature Communications. 8(1). 1632–1632. 19 indexed citations
4.
Eccles, Diana, Tom Maishman, William Tapper, et al.. (2017). Abstract S2-03: Does BRCA status affect outcome in young breast cancer patients? Results from the prospective study of outcomes in sporadic and hereditary breast cancer (POSH). Cancer Research. 77(4_Supplement). S2–3. 3 indexed citations
5.
Maishman, Tom, Ramsey Cutress, Sue Gerty, et al.. (2016). Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer. Annals of Surgery. 266(1). 165–172. 79 indexed citations
6.
Eccles, Diana, Na Li, Tom Maishman, et al.. (2015). Genetic testing in a cohort of young patients with HER2-amplified breast cancer. Annals of Oncology. 27(3). 467–473. 20 indexed citations
7.
Maishman, Tom, Ellen Copson, Louise Stanton, et al.. (2015). An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis. British Journal of Cancer. 112(6). 983–991. 30 indexed citations
8.
Copson, Ellen, Ramsey Cutress, Tom Maishman, et al.. (2014). Obesity and the outcome of young breast cancer patients in the UK: the POSH study. Annals of Oncology. 26(1). 101–112. 65 indexed citations
9.
Copson, Ellen, Tom Maishman, Susan M. Gerty, et al.. (2013). Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. British Journal of Cancer. 110(1). 230–241. 56 indexed citations
10.
Copson, Ellen, Bryony Eccles, Tom Maishman, et al.. (2013). Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study. JNCI Journal of the National Cancer Institute. 105(13). 978–988. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. I. Li Breakdown of academic impact, for papers by В. В. Семиглазов Breakdown of academic impact, for papers by Shan Zheng Breakdown of academic impact, for papers by Fredrika Killander Breakdown of academic impact, for papers by Sabine Pöstlberger Breakdown of academic impact, for papers by Olivier Brouckaert Breakdown of academic impact, for papers by A. Michelotti Breakdown of academic impact, for papers by Mauricio Camus Breakdown of academic impact, for papers by Hatef Darabi Breakdown of academic impact, for papers by Sara Taylor
Rankless by CCL
2026